# Carbidopa and Levodopa

NDC: 50228-460
Generic name: Carbidopa and Levodopa
Labeler / Manufacturer: ScieGen Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20211005

FDA application: ANDA214091

## Active ingredients

- CARBIDOPA: 25 mg/1
- LEVODOPA: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50228-460"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50228-460
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b17ab1e-f3c1-4343-ba28-e2901cd97d43